000 01444 a2200433 4500
005 20250516170812.0
264 0 _c20140408
008 201404s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2013.265
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrövdal, M
245 0 0 _aAzacitidine induces profound genome-wide hypomethylation in primary myelodysplastic bone marrow cultures but may also reduce histone acetylation.
_h[electronic resource]
260 _bLeukemia
_cFeb 2014
300 _a411-3 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAcetylation
_xdrug effects
650 0 4 _aAntimetabolites, Antineoplastic
_xpharmacology
650 0 4 _aAzacitidine
_xpharmacology
650 0 4 _aBone Marrow Cells
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDNA Methylation
_xdrug effects
650 0 4 _aEpigenesis, Genetic
_xdrug effects
650 0 4 _aEpigenomics
650 0 4 _aHistones
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMyelodysplastic Syndromes
_xgenetics
700 1 _aKarimi, M
700 1 _aTobiasson, M
700 1 _aReinius, L
700 1 _aJansson, M
700 1 _aEkwall, K
700 1 _aUngerstedt, J
700 1 _aKere, J
700 1 _aGreco, D
700 1 _aHellström-Lindberg, E
773 0 _tLeukemia
_gvol. 28
_gno. 2
_gp. 411-3
856 4 0 _uhttps://doi.org/10.1038/leu.2013.265
_zAvailable from publisher's website
999 _c23078341
_d23078341